
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $262.9M | -- | -- | $0.05 | -- |
08/05/2025 | Q2 | $254.7M | -- | -- | -$0.02 | -- |
05/07/2025 | Q1 | $245.1M | $247.7M | -$0.14 | -$0.03 | -$0.11 |
02/26/2025 | Q4 | $238M | $242.9M | -$0.58 | -$0.03 | -$0.55 |
11/06/2024 | Q3 | $226.9M | $227.7M | -$0.36 | -$0.05 | -$0.32 |
08/05/2024 | Q2 | $225.9M | $226M | -$0.63 | -$0.09 | -$0.54 |
05/06/2024 | Q1 | $224M | $226.2M | -$4.12 | -$0.11 | -$4.01 |
02/27/2024 | Q4 | $229.1M | $225.5M | -$1.40 | -$0.10 | -$1.31 |
11/06/2023 | Q3 | -- | -- | -$1.00 | -$0.11 | -$0.90 |
08/07/2023 | Q2 | -- | -- | -$0.50 | -$0.01 | -$0.49 |
05/08/2023 | Q1 | -- | -- | -$0.51 | $0.04 | -$0.55 |
02/20/2023 | Q4 | -- | -- | $0.49 | $0.16 | $0.33 |
11/07/2022 | Q3 | -- | -- | -$0.57 | $0.19 | -$0.76 |
08/03/2022 | Q2 | -- | -- | $0.04 | $0.11 | -$0.07 |
05/04/2022 | Q1 | -- | -- | -$0.02 | $0.05 | -$0.07 |
02/02/2022 | Q4 | -- | -- | -$0.09 | -$0.02 | -$0.07 |
11/01/2021 | Q3 | -- | -- | -$0.21 | $0.07 | -$0.28 |
08/04/2021 | Q2 | -- | -- | $0.10 | $0.12 | -$0.02 |
05/05/2021 | Q1 | -- | -- | $0.02 | -- | -- |
02/03/2021 | Q4 | -- | -- | $0.13 | -- | -- |
11/02/2020 | Q3 | -- | -- | $0.11 | -- | -- |
08/05/2020 | Q2 | -- | -- | $0.02 | -- | -- |
05/06/2020 | Q1 | -- | -- | -$0.21 | -- | -- |
02/05/2020 | Q4 | -- | -- | -$0.26 | -- | -- |
10/30/2019 | Q3 | -- | -- | -$0.96 | -- | -- |
07/17/2019 | Q2 | -- | -- | $0.08 | -- | -- |
04/17/2019 | Q1 | -- | -- | $0.02 | -- | -- |
01/23/2019 | Q4 | -- | -- | -$0.18 | -- | -- |
10/16/2018 | Q3 | -- | -- | $0.16 | -- | -- |
07/17/2018 | Q2 | -- | -- | -$0.16 | -- | -- |
04/17/2018 | Q1 | -- | -- | -$0.22 | -- | -- |
01/17/2018 | Q4 | -- | -- | -$0.23 | -- | -- |
10/17/2017 | Q3 | -- | -- | $0.33 | -- | -- |
07/18/2017 | Q2 | -- | -- | $0.26 | -- | -- |
04/18/2017 | Q1 | -- | -- | $0.14 | -- | -- |
01/18/2017 | Q4 | -- | -- | $0.16 | -- | -- |
10/18/2016 | Q3 | -- | -- | $0.26 | -- | -- |
07/13/2016 | Q2 | -- | -- | $0.21 | -- | -- |
04/12/2016 | Q1 | -- | -- | $0.10 | -- | -- |
01/19/2016 | Q4 | -- | -- | $0.12 | -- | -- |
10/13/2015 | Q3 | -- | -- | $0.14 | -- | -- |
Adtran Holdings reported $247.7M worth of top line sales in its most recent quarter.
Adtran Holdings announced earnings per share of -$0.14 which represents a miss of analyst forecast a -$0.03 per share.
Adtran Holdings reported $95.2M that represents $1.20 per share over the last quarter.
Adtran Holdings's earnings are forecast to decrease from -$5.79 per share to -$0.35 per share next year representing a decrease of -89.87%.
Adtran Holdings's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.